Therefore, SIRT5 might serve as a prognostic factor for ovarian cancer and SIRT5 inhibitors combined with chemotherapy could represent a novel therapeutic strategy for ovarian cancer patients. The gene discussed is SIRT5; the disease is ovarian carcinoma.